Your browser doesn't support javascript.
loading
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Abid, Muhammad Bilal; Estrada-Merly, Noel; Zhang, Mei-Jie; Chen, Karen; Bredeson, Christopher; Allan, David; Sabloff, Mitchell; Marks, David I; Litzow, Mark; Hourigan, Christopher; Kebriaei, Partow; Saber, Wael.
Affiliation
  • Abid MB; Divisions of Hematology/Oncology & Infectious Diseases, BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee,
  • Estrada-Merly N; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Zhang MJ; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Chen K; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bredeson C; Ottawa Hospital TCT Programme and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Allan D; Ottawa Hospital TCT Programme and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Sabloff M; Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Marks DI; Bristol Hematology and Oncology Unit, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Litzow M; Division of Hematology, Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, Minnesota.
  • Hourigan C; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Kebriaei P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Saber W; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Transplant Cell Ther ; 29(10): 611-618, 2023 Oct.
Article de En | MEDLINE | ID: mdl-37481243
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Transplantation de cellules souches hématopoïétiques / Leucémie-lymphome lymphoblastique à précurseurs B et T / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies / Risk_factors_studies Limites: Adult / Aged / Humans / Middle aged Langue: En Journal: Transplant Cell Ther Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome lymphoblastique à précurseurs B / Transplantation de cellules souches hématopoïétiques / Leucémie-lymphome lymphoblastique à précurseurs B et T / Maladie du greffon contre l'hôte Type d'étude: Etiology_studies / Risk_factors_studies Limites: Adult / Aged / Humans / Middle aged Langue: En Journal: Transplant Cell Ther Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique